ORGANISATION/COMPANYMasaryk University, Faculty of Medicine
RESEARCH FIELDMedical sciences › Medicine
RESEARCHER PROFILEFirst Stage Researcher (R1)
APPLICATION DEADLINE31/10/2022 00:00 - Europe/Brussels
OFFER STARTING DATE01/03/2023
We are looking for a motivated PhD student that would like to work on the following project funded by the ERC (European Research Council) Starting grant. Follicular lymphoma (FL) is a type of blood cancer that originates from B-lymphocytes, and it is the most common type of indolent non-Hodgkin lymphoma. The clinical course of FL patients can be surprisingly variable (survival from months to decades) and FL still remains incurable. The course of the disease is characterized by repeated relapses leading to the evolution of resistant disease or to the high-grade transformation to a more aggressive diffuse large B-cell lymphoma (DLBCL). This is associated with remarkably poor prognosis and a high risk of early death. Number of studies showed that multiple genetic lesions are associated with FL transformation (tFL); however, precise molecular mechanisms underlying this process is largely unclear. Importantly, the role of long non-coding RNAs in this process is completely unknown. However, we have recently described the role of short-noncoding miRNAs roles in transformed FL (Musilova et al…Mraz, Blood, 2018). The aim of the project is to reveal the molecular mechanisms involving lncRNAs and/or miRNAs responsible for FL transformation. The primary samples collected before and after high-grade transformation will be analyzed on the level of protein-coding as well as non-coding genes (NGS with Illumina, preliminary data available). This will be followed by searching for function of tFL-associated lncRNAs. This will help to better understand the disease biology and possibly to identify novel molecular targets that could be used therapeutically.
- Sharma et al. …Mraz. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. Blood 2020 Nov (epub). https://pubmed.ncbi.nlm.nih.gov/33171493/
- Musilova et al. …Mraz. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels . BLOOD. 2018 NOV 29;132(22):2389-2400. https://pubmed.ncbi.nlm.nih.gov/33786575/
- Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015 May;29(5):1004-17Zeni and Mraz LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biol. 2021 May;18(5):619-632. https://pubmed.ncbi.nlm.nih.gov/33094664/
Part-time salary (min. 0,5 FTE) on AZV/ERC/GACR grants + national scholarship (equals approx. half-time salary)
Requirements on candidates:
- Motivated smart people that have the “drive” to work independently, but also willing to learn from other people in the lab and collaborate.
- Candidates should have a master’s degree in Molecular biology, Biochemistry, or similar field and have deep interest in molecular biology and cancer cell biology.
Keywords: Long non-coding RNA, lymphomas, DLBCL, miRNA
Number of positions: 1
Information on the supervisor:
H-index 22 (citations at WOS > 1600, 46 publications with IF), currently principal investigator of 4 fundings (AZV, ERC, GAMU, NPÚ), international collaborations: University of Southampton, UCSD, Mayo Clinic, Dana-Farber Cancer Institute, EMBL, University of Turin (student internship available), member of EHA Committee, a reviewer in scientific journals: Blood, Leukemia, Leuk Lymphoma, Leukemia Research; https://is.muni.cz/auth/osoba/101627; ceitec.cz/mrazlab
EURAXESS offer ID: 839115
Posting organisation offer ID: 15619
The responsibility for the jobs published on this website, including the job description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.
Please contact email@example.com if you wish to download all jobs in XML.